2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …
A Vahanian, F Beyersdorf, F Praz… - European heart …, 2022 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …
when exercising their clinical judgment, as well as in the determination and the …
2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …
F Beyersdorf, A Vahanian, M Milojevic… - European journal of …, 2021 - academic.oup.com
731 F. Beyersdorf and A. Vahanian et al./European Journal of Cardio-Thoracic Surgery
guidelines, which is freely available via the ESC and EACTS website and hosted on the EHJ …
guidelines, which is freely available via the ESC and EACTS website and hosted on the EHJ …
2-year outcomes of transcatheter mitral valve replacement in patients with annular calcification, rings, and bioprostheses
MF Eleid, DD Wang, A Pursnani, SK Kodali… - Journal of the American …, 2022 - jacc.org
Abstract Background The MITRAL (Mitral Implantation of Transcatheter Valves) trial is the
first prospective study for valve-in-mitral annular calcification (ViMAC), mitral valve-in-ring …
first prospective study for valve-in-mitral annular calcification (ViMAC), mitral valve-in-ring …
Prospective evaluation of transseptal TMVR for failed surgical bioprostheses: MITRAL trial valve-in-valve arm 1-year outcomes
M Guerrero, A Pursnani, A Narang, M Salinger… - Cardiovascular …, 2021 - jacc.org
Objectives The aim of this study was to assess 1-year clinical outcomes among high-risk
patients with failed surgical mitral bioprostheses who underwent transseptal mitral valve-in …
patients with failed surgical mitral bioprostheses who underwent transseptal mitral valve-in …
Transcatheter mitral valve implantation: current status and future perspectives
G Russo, M Gennari, M Gavazzoni… - Circulation …, 2021 - Am Heart Assoc
Mitral transcatheter therapies represent the treatment of choice for all patients deemed
unsuitable for cardiac surgery. So far, the largest clinical experience has been limited to …
unsuitable for cardiac surgery. So far, the largest clinical experience has been limited to …
Prospective evaluation of TMVR for failed surgical annuloplasty rings: MITRAL trial valve-in-ring arm 1-year outcomes
M Guerrero, DD Wang, A Pursnani, M Salinger… - Cardiovascular …, 2021 - jacc.org
Objectives The authors report 1-year outcomes of high-risk patients with failed surgical
annuloplasty rings undergoing transseptal mitral valve–in–ring (MViR) with the SAPIEN 3 …
annuloplasty rings undergoing transseptal mitral valve–in–ring (MViR) with the SAPIEN 3 …
5-year prospective evaluation of mitral valve-in-valve, valve-in-ring, and valve-in-MAC outcomes: MITRAL trial final results
ME Guerrero, MF Eleid, DD Wang, A Pursnani… - Cardiovascular …, 2023 - jacc.org
Abstract Background The MITRAL (Mitral Implantation of Transcatheter Valves) trial is the
first prospective trial to evaluate the safety and feasibility of balloon-expandable aortic …
first prospective trial to evaluate the safety and feasibility of balloon-expandable aortic …
Guía ESC/EACTS 2021 sobre el diagnóstico y tratamiento de las valvulopatías: Desarrollada por el Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) y …
A Vahanian, F Beyersdorf, F Praz, M Milojevic… - Revista española de …, 2022 - Elsevier
Abstract The True Infection Rate (TIR) in the whole population of each country and the
Infection Fatality Rate (IFR) for coronavirus disease 2019 (COVID-19) are unknown although …
Infection Fatality Rate (IFR) for coronavirus disease 2019 (COVID-19) are unknown although …
Transcatheter valve-in-valve implantation in degenerated surgical aortic and mitral bioprosthesis: Current state and future perspectives
A Alperi, S Garcia, J Rodes-Cabau - Progress in Cardiovascular Diseases, 2022 - Elsevier
The use of bioprosthetic valves for treating patients with severe valve disease has increased
over the last 2 decades, and, as a consequence, a growing number of patients with failing …
over the last 2 decades, and, as a consequence, a growing number of patients with failing …
[HTML][HTML] Meta-analysis comparing valve-in-valve transcatheter mitral valve replacement versus redo surgical mitral valve replacement in degenerated bioprosthetic …
M Ismayl, MA Abbasi, MR Mostafa, A Aboeata… - The American Journal of …, 2023 - Elsevier
Valve-in-valve transcatheter mitral valve replacement (ViV-TMVR) and redo surgical mitral
valve replacement (redo-SMVR) are 2 treatment strategies for patients with bioprosthetic …
valve replacement (redo-SMVR) are 2 treatment strategies for patients with bioprosthetic …